Showing results (401-410 of 454) with videos related to
Sort By:
Pageof 46
The European Respiratory Journal|November 1, 1995
Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthmaM Kraft, C M Bettinger, S E Wenzel, et al.The Journal of Allergy and Clinical Immunology|June 1, 1995
Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contaminationH Kita, A N Mayeno, C M Weyand, et al.Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-AJ B Lawrence, C Oxvig, M T Overgaard, et al.The American Review of Respiratory Disease|April 1, 1993
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reactionT Ohnishi, H Kita, D Weiler, et al.The American Review of Respiratory Disease|September 1, 1993
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?S Sur, T B Crotty, G M Kephart, et al.The American Review of Respiratory Disease|July 1, 1989
Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitroG H Ayars, L C Altman, M M McManus, et al.Blood|September 15, 1991
Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancerC van Haelst Pisani, J S Kovach, H Kita, et al.Clinical Therapeutics|March 1, 1997
The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitisC A Alvarado-Valdés, J Blomgren, D Weiler, et al.Genomics|February 15, 2001
Comparative structure, proximal promoter elements, and chromosome location of the human eosinophil major basic protein genesD A Plager, D A Weiler, D A Loegering, et al.Pharmacoeconomics|June 3, 1999
Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALSS J Ackerman, E M Sullivan, K M Beusterien, et al.Pageof 46